{"filing":{"accession_number":"0000950103-26-015940","cik":"0000003124","ticker":null,"company_name":"AKZO NOBEL NV","form":"6-K","filing_date":"2026-10-21","report_date":"2026-10-21","primary_document":"dp255340_6k-3.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/3124/000095010326015940/dp255340_6k-3.htm"},"events":[{"id":36636,"run_id":33780,"accession_number":"0000950103-26-015940","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a media release announcing AkzoNobel's Q3 2026 financial results, including organic sales growth of +2%, adjusted EBITDA margin expansion to 15.3%, and full-year 2026 adjusted EBITDA guidance of approximately €1.47 billion. The document explicitly states \"Akzo Nobel N.V. publishes results for Q3 2026\" and presents key financial metrics and performance highlights typical of a quarterly earnings announcement. While the release also mentions the pending Axalta merger and a divestment agreement, the primary disclosure is the quarterly financial results.","company_name":"AKZO NOBEL NV","ticker":null,"filing_date":"2026-10-21","form":"6-K","submitted_at":null,"items":[{"id":41111,"accession_number":"0000950103-26-015940","item_number":"EX-99.1","item_title":"dp255340_ex9901.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a media release announcing AkzoNobel's Q3 2026 financial results, including organic sales growth of +2%, adjusted EBITDA margin expansion to 15.3%, and full-year 2026 adjusted EBITDA guidance of approximately €1.47 billion. The document explicitly states \"Akzo Nobel N.V. publishes results for Q3 2026\" and presents key financial metrics and performance highlights typical of a quarterly earnings announcement. While the release also mentions the pending Axalta merger and a divestment agreement, the primary disclosure is the quarterly financial results.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-21T12:50:37.721944+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":41111,"accession_number":"0000950103-26-015940","item_number":"EX-99.1","item_title":"dp255340_ex9901.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a media release announcing AkzoNobel's Q3 2026 financial results, including organic sales growth of +2%, adjusted EBITDA margin expansion to 15.3%, and full-year 2026 adjusted EBITDA guidance of approximately €1.47 billion. The document explicitly states \"Akzo Nobel N.V. publishes results for Q3 2026\" and presents key financial metrics and performance highlights typical of a quarterly earnings announcement. While the release also mentions the pending Axalta merger and a divestment agreement, the primary disclosure is the quarterly financial results.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-21T12:50:37.721944+00:00","company_name":"AKZO NOBEL NV","ticker":null,"filing_date":"2026-10-21"}]}